Menu Close
The Conversation

Radhika Puttagunta

1

Article

1

Comment
Post-doctoral researcher at the Hertie Institute for Clinical Brain Research, University of Tübingen

Radhika Puttagunta is a senior post-doctoral scientist in the Neuroregeneration Lab at the Hertie Institute for Clinical Brain Research. She previously worked on stimulating neurite outgrowth in primary central nervous system neurons with the treatment of retinoic acid which blocked the expression of an inhibitory myelin protein (Lingo-1, part of the Nogo-R complex that inhibits axonal regeneration) as well as studying the role that mitochondrial heat shock protein 70 plays in stress resistance and aging.

Experience

  • 2007–present
    Post-doctoral researcher at the Hertie Institute for Clinical Brain Research, University of Tübingen

Education

  • 2006 
    University of Wisconsin-Madison, PhD and M.S.
  • 1998 
    University of Michigan-Ann Arbor, M.S. and B.S.

Publications

  • 2013
    Epigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward., Neurotherapeutics
  • 2012
    Retinoic acid signaling in axonal regeneration., Frontiers in Molecular Neuroscience
  • 2011
    RA-RAR-β counteracts myelin-dependent inhibition of neurite outgrowth via Lingo-1 repression., Journal of Cell Biology
  • 2010
    HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation., Cell Death and Differentiation
  • 2009
    A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration., Cell Death and Differentiation
  • 2003
    Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse., Nature Genetics
  • 2000
    Comparative maps of human 19p13.3 and mouse chromosome 10 allow identification of sequences at evolutionary breakpoints., Genome Research